Max Seibold
Concepts (409)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 55 | 2025 | 1894 | 6.580 |
Why?
| | Respiratory Mucosa | 14 | 2024 | 322 | 3.670 |
Why?
| | Interleukin-13 | 11 | 2024 | 148 | 3.020 |
Why?
| | Transcriptome | 10 | 2022 | 969 | 2.550 |
Why?
| | Mucin 5AC | 6 | 2024 | 70 | 2.220 |
Why?
| | Nasal Mucosa | 8 | 2024 | 106 | 2.030 |
Why?
| | Gene Expression Profiling | 16 | 2020 | 1748 | 1.920 |
Why?
| | Epithelial Cells | 14 | 2024 | 1103 | 1.910 |
Why?
| | Adrenal Cortex Hormones | 9 | 2025 | 496 | 1.640 |
Why?
| | Hypersensitivity | 5 | 2024 | 254 | 1.450 |
Why?
| | Lectins | 2 | 2024 | 46 | 1.330 |
Why?
| | Mucus | 3 | 2024 | 78 | 1.160 |
Why?
| | Bronchodilator Agents | 7 | 2025 | 197 | 1.010 |
Why?
| | Lung | 13 | 2023 | 4107 | 0.980 |
Why?
| | Common Cold | 1 | 2025 | 15 | 0.960 |
Why?
| | Polymorphism, Single Nucleotide | 17 | 2022 | 2139 | 0.960 |
Why?
| | Mucin-5B | 5 | 2020 | 222 | 0.940 |
Why?
| | Genetic Predisposition to Disease | 14 | 2019 | 2363 | 0.920 |
Why?
| | Th2 Cells | 6 | 2023 | 178 | 0.900 |
Why?
| | Particulate Matter | 3 | 2025 | 319 | 0.870 |
Why?
| | Inhalation Exposure | 1 | 2025 | 107 | 0.850 |
Why?
| | GPI-Linked Proteins | 1 | 2024 | 76 | 0.850 |
Why?
| | Environmental Exposure | 4 | 2025 | 569 | 0.840 |
Why?
| | Picornaviridae Infections | 5 | 2025 | 49 | 0.830 |
Why?
| | Epithelium | 3 | 2023 | 316 | 0.820 |
Why?
| | Hexosaminidases | 2 | 2016 | 18 | 0.780 |
Why?
| | Air Pollutants | 3 | 2025 | 425 | 0.780 |
Why?
| | Air Pollution, Indoor | 1 | 2025 | 183 | 0.760 |
Why?
| | Virus Diseases | 1 | 2025 | 214 | 0.760 |
Why?
| | Interferons | 2 | 2020 | 195 | 0.750 |
Why?
| | Environmental Monitoring | 1 | 2025 | 365 | 0.740 |
Why?
| | Single-Cell Analysis | 4 | 2021 | 322 | 0.730 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2021 | 55 | 0.710 |
Why?
| | Severity of Illness Index | 6 | 2025 | 2853 | 0.710 |
Why?
| | Rhinovirus | 5 | 2025 | 56 | 0.700 |
Why?
| | Child | 34 | 2025 | 21946 | 0.700 |
Why?
| | Sequence Analysis, RNA | 8 | 2021 | 449 | 0.700 |
Why?
| | Idiopathic Pulmonary Fibrosis | 5 | 2020 | 657 | 0.670 |
Why?
| | Trachea | 2 | 2020 | 255 | 0.660 |
Why?
| | Enterovirus Infections | 2 | 2023 | 172 | 0.660 |
Why?
| | Humans | 86 | 2025 | 139072 | 0.660 |
Why?
| | Serine Endopeptidases | 1 | 2020 | 119 | 0.640 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2018 | 543 | 0.630 |
Why?
| | Gene Expression Regulation | 9 | 2023 | 2591 | 0.620 |
Why?
| | Alveolar Epithelial Cells | 2 | 2018 | 114 | 0.610 |
Why?
| | Quantitative Trait Loci | 3 | 2020 | 362 | 0.610 |
Why?
| | Respiratory Tract Infections | 3 | 2020 | 383 | 0.590 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 372 | 0.580 |
Why?
| | Coronavirus Infections | 2 | 2020 | 369 | 0.580 |
Why?
| | Betacoronavirus | 2 | 2020 | 273 | 0.580 |
Why?
| | Case-Control Studies | 14 | 2025 | 3577 | 0.570 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 3 | 2019 | 25 | 0.570 |
Why?
| | Dermatitis, Atopic | 5 | 2019 | 331 | 0.570 |
Why?
| | STAT6 Transcription Factor | 1 | 2018 | 27 | 0.570 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2018 | 56 | 0.560 |
Why?
| | Genome, Human | 2 | 2018 | 418 | 0.550 |
Why?
| | Smoking | 2 | 2020 | 1610 | 0.550 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 1045 | 0.540 |
Why?
| | Host-Pathogen Interactions | 2 | 2020 | 370 | 0.540 |
Why?
| | Cadherins | 1 | 2019 | 203 | 0.530 |
Why?
| | Gene Editing | 1 | 2018 | 84 | 0.520 |
Why?
| | RNA Virus Infections | 1 | 2017 | 20 | 0.520 |
Why?
| | CRISPR-Cas Systems | 1 | 2018 | 134 | 0.500 |
Why?
| | Gene Deletion | 1 | 2018 | 389 | 0.490 |
Why?
| | Amides | 1 | 2016 | 97 | 0.480 |
Why?
| | Adipokines | 1 | 2016 | 47 | 0.470 |
Why?
| | RNA Viruses | 1 | 2017 | 76 | 0.470 |
Why?
| | Sputum | 6 | 2025 | 305 | 0.470 |
Why?
| | Adolescent | 27 | 2025 | 21594 | 0.460 |
Why?
| | Male | 46 | 2025 | 68299 | 0.460 |
Why?
| | Steroids | 1 | 2016 | 163 | 0.450 |
Why?
| | Genome-Wide Association Study | 8 | 2023 | 1391 | 0.440 |
Why?
| | Female | 46 | 2025 | 74071 | 0.430 |
Why?
| | Inflammation | 7 | 2023 | 2853 | 0.430 |
Why?
| | Forced Expiratory Volume | 5 | 2020 | 488 | 0.430 |
Why?
| | Polymorphism, Genetic | 4 | 2024 | 624 | 0.430 |
Why?
| | Pulmonary Fibrosis | 2 | 2023 | 399 | 0.410 |
Why?
| | Membrane Proteins | 2 | 2020 | 1149 | 0.410 |
Why?
| | Pyridines | 1 | 2016 | 494 | 0.390 |
Why?
| | Child, Preschool | 13 | 2025 | 11171 | 0.380 |
Why?
| | Chitinases | 2 | 2009 | 9 | 0.380 |
Why?
| | Stem Cells | 1 | 2016 | 599 | 0.370 |
Why?
| | Haplotypes | 3 | 2011 | 497 | 0.360 |
Why?
| | Gene Expression | 7 | 2023 | 1488 | 0.360 |
Why?
| | Bronchi | 5 | 2020 | 269 | 0.350 |
Why?
| | Metaplasia | 2 | 2022 | 58 | 0.350 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 59 | 0.350 |
Why?
| | Air Pollution | 3 | 2020 | 314 | 0.350 |
Why?
| | Lung Diseases | 1 | 2018 | 785 | 0.340 |
Why?
| | Adult | 28 | 2025 | 38428 | 0.340 |
Why?
| | Cells, Cultured | 7 | 2020 | 4183 | 0.330 |
Why?
| | Allergens | 4 | 2021 | 400 | 0.330 |
Why?
| | Middle Aged | 20 | 2025 | 33811 | 0.330 |
Why?
| | Animals | 22 | 2023 | 37261 | 0.330 |
Why?
| | Mexican Americans | 3 | 2022 | 114 | 0.330 |
Why?
| | Disease Progression | 5 | 2025 | 2752 | 0.320 |
Why?
| | Genomics | 4 | 2024 | 797 | 0.300 |
Why?
| | Mice | 16 | 2023 | 17836 | 0.300 |
Why?
| | Genotype | 8 | 2019 | 1849 | 0.290 |
Why?
| | Gene-Environment Interaction | 3 | 2020 | 186 | 0.290 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2008 | 8 | 0.290 |
Why?
| | Cell Differentiation | 6 | 2018 | 1994 | 0.290 |
Why?
| | Prospective Studies | 7 | 2025 | 7666 | 0.280 |
Why?
| | Urban Population | 3 | 2024 | 485 | 0.280 |
Why?
| | NIH 3T3 Cells | 2 | 2020 | 148 | 0.280 |
Why?
| | Linkage Disequilibrium | 6 | 2020 | 258 | 0.280 |
Why?
| | Cellular Reprogramming | 2 | 2020 | 98 | 0.270 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2022 | 335 | 0.270 |
Why?
| | Cytokines | 5 | 2024 | 2084 | 0.270 |
Why?
| | Cohort Studies | 5 | 2025 | 5749 | 0.260 |
Why?
| | DNA Methylation | 3 | 2023 | 636 | 0.250 |
Why?
| | Minority Groups | 3 | 2022 | 275 | 0.250 |
Why?
| | Interleukin-33 | 2 | 2016 | 51 | 0.250 |
Why?
| | Young Adult | 15 | 2025 | 13378 | 0.250 |
Why?
| | Genetic Variation | 4 | 2020 | 990 | 0.250 |
Why?
| | Enterovirus | 3 | 2024 | 85 | 0.240 |
Why?
| | Cilia | 2 | 2020 | 172 | 0.240 |
Why?
| | Oscillometry | 1 | 2025 | 36 | 0.240 |
Why?
| | Basement Membrane | 1 | 2025 | 33 | 0.230 |
Why?
| | Rhinitis, Allergic | 1 | 2025 | 42 | 0.230 |
Why?
| | Immunity, Innate | 2 | 2021 | 827 | 0.220 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2024 | 33 | 0.220 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 365 | 0.220 |
Why?
| | Lung Diseases, Interstitial | 1 | 2011 | 651 | 0.220 |
Why?
| | Transcription Factors | 4 | 2023 | 1701 | 0.220 |
Why?
| | Risk Factors | 7 | 2025 | 10390 | 0.220 |
Why?
| | Albuterol | 3 | 2023 | 74 | 0.210 |
Why?
| | Genetic Association Studies | 2 | 2016 | 374 | 0.210 |
Why?
| | Skin | 2 | 2019 | 756 | 0.210 |
Why?
| | Puerto Rico | 5 | 2020 | 53 | 0.210 |
Why?
| | Viral Load | 1 | 2025 | 495 | 0.200 |
Why?
| | Pandemics | 3 | 2021 | 1645 | 0.200 |
Why?
| | Helminthiasis | 1 | 2023 | 12 | 0.200 |
Why?
| | Chemokine CCL5 | 1 | 2023 | 43 | 0.200 |
Why?
| | Family Characteristics | 1 | 2024 | 192 | 0.200 |
Why?
| | Nasal Polyps | 1 | 2023 | 61 | 0.190 |
Why?
| | Treatment Outcome | 5 | 2025 | 10930 | 0.190 |
Why?
| | Pulmonary Surfactants | 1 | 2023 | 104 | 0.190 |
Why?
| | Epigenesis, Genetic | 3 | 2023 | 644 | 0.180 |
Why?
| | Salmeterol Xinafoate | 1 | 2021 | 22 | 0.180 |
Why?
| | Fluticasone | 1 | 2021 | 56 | 0.180 |
Why?
| | Anti-Asthmatic Agents | 1 | 2024 | 266 | 0.180 |
Why?
| | Surgical Tape | 2 | 2019 | 5 | 0.180 |
Why?
| | Strongylida Infections | 1 | 2021 | 7 | 0.180 |
Why?
| | Macrophages, Alveolar | 2 | 2019 | 396 | 0.180 |
Why?
| | Down-Regulation | 2 | 2021 | 636 | 0.170 |
Why?
| | Pharmacogenomic Testing | 1 | 2021 | 60 | 0.170 |
Why?
| | Cystic Fibrosis | 2 | 2022 | 1102 | 0.170 |
Why?
| | Rhinitis | 1 | 2023 | 171 | 0.170 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2020 | 31 | 0.170 |
Why?
| | Interleukin-4 | 2 | 2020 | 214 | 0.170 |
Why?
| | Gene Regulatory Networks | 2 | 2020 | 310 | 0.170 |
Why?
| | Gene Frequency | 3 | 2011 | 502 | 0.170 |
Why?
| | Respiratory Function Tests | 4 | 2025 | 561 | 0.170 |
Why?
| | Epidermis | 2 | 2019 | 157 | 0.170 |
Why?
| | fas Receptor | 1 | 2020 | 97 | 0.170 |
Why?
| | Virus Internalization | 1 | 2020 | 65 | 0.170 |
Why?
| | Biomarkers | 4 | 2022 | 4095 | 0.170 |
Why?
| | Administration, Inhalation | 5 | 2025 | 595 | 0.160 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2020 | 71 | 0.160 |
Why?
| | Stem Cell Factor | 1 | 2020 | 17 | 0.160 |
Why?
| | Keratinocytes | 2 | 2018 | 252 | 0.160 |
Why?
| | Sinusitis | 1 | 2023 | 237 | 0.160 |
Why?
| | Signal Transduction | 5 | 2020 | 5095 | 0.160 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 116 | 0.160 |
Why?
| | Coronavirus | 1 | 2020 | 47 | 0.160 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 117 | 0.160 |
Why?
| | Neutrophils | 3 | 2023 | 1274 | 0.150 |
Why?
| | Cadherin Related Proteins | 1 | 2019 | 13 | 0.150 |
Why?
| | Smokers | 1 | 2020 | 144 | 0.150 |
Why?
| | Clinical Decision-Making | 1 | 2022 | 334 | 0.150 |
Why?
| | Biological Transport | 1 | 2020 | 403 | 0.150 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2020 | 124 | 0.150 |
Why?
| | Eczema | 1 | 2019 | 70 | 0.150 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2019 | 30 | 0.150 |
Why?
| | Lymphocytes | 1 | 2021 | 396 | 0.150 |
Why?
| | CD11c Antigen | 1 | 2019 | 41 | 0.150 |
Why?
| | Immunologic Memory | 1 | 2021 | 357 | 0.150 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 2018 | 8 | 0.150 |
Why?
| | Clone Cells | 2 | 2016 | 265 | 0.150 |
Why?
| | Dendritic Cells | 2 | 2019 | 491 | 0.150 |
Why?
| | Cell Line | 5 | 2020 | 2880 | 0.150 |
Why?
| | Smad2 Protein | 1 | 2018 | 38 | 0.150 |
Why?
| | Pharmacogenetics | 2 | 2010 | 164 | 0.140 |
Why?
| | Receptors, Odorant | 1 | 2018 | 32 | 0.140 |
Why?
| | Pharmacogenomic Variants | 1 | 2018 | 33 | 0.140 |
Why?
| | Acetyltransferases | 1 | 2018 | 21 | 0.140 |
Why?
| | Airway Remodeling | 1 | 2018 | 63 | 0.140 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2533 | 0.140 |
Why?
| | Molecular Sequence Annotation | 1 | 2018 | 95 | 0.140 |
Why?
| | Spirometry | 3 | 2025 | 263 | 0.140 |
Why?
| | Eosinophilia | 1 | 2020 | 218 | 0.130 |
Why?
| | Sequence Analysis, DNA | 2 | 2018 | 824 | 0.130 |
Why?
| | Epigenomics | 2 | 2023 | 114 | 0.130 |
Why?
| | Glycoproteins | 1 | 2019 | 354 | 0.130 |
Why?
| | Aged | 8 | 2025 | 24186 | 0.130 |
Why?
| | Cell-Matrix Junctions | 1 | 2016 | 2 | 0.130 |
Why?
| | Phosphoproteins | 1 | 2019 | 340 | 0.130 |
Why?
| | Cockroaches | 1 | 2016 | 22 | 0.130 |
Why?
| | Emergency Service, Hospital | 2 | 2025 | 2114 | 0.120 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2017 | 99 | 0.120 |
Why?
| | Nose | 1 | 2016 | 65 | 0.120 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2016 | 86 | 0.120 |
Why?
| | Disease Susceptibility | 2 | 2025 | 349 | 0.120 |
Why?
| | Culture Media | 1 | 2016 | 164 | 0.120 |
Why?
| | Food Hypersensitivity | 1 | 2019 | 182 | 0.120 |
Why?
| | Bronchiolitis, Viral | 1 | 2015 | 11 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 464 | 0.120 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1092 | 0.120 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 364 | 0.120 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2015 | 33 | 0.120 |
Why?
| | Fibroblasts | 2 | 2020 | 1003 | 0.120 |
Why?
| | Genomic Imprinting | 1 | 2015 | 26 | 0.120 |
Why?
| | Influenza, Human | 1 | 2021 | 614 | 0.110 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2021 | 1098 | 0.110 |
Why?
| | Genetic Testing | 1 | 2018 | 454 | 0.110 |
Why?
| | Indians, North American | 1 | 2020 | 645 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 509 | 0.110 |
Why?
| | Cell Communication | 1 | 2016 | 316 | 0.110 |
Why?
| | Pulmonary Emphysema | 1 | 2017 | 311 | 0.110 |
Why?
| | Up-Regulation | 2 | 2018 | 853 | 0.110 |
Why?
| | Lipid Metabolism | 1 | 2018 | 523 | 0.110 |
Why?
| | Alternative Splicing | 1 | 2016 | 227 | 0.110 |
Why?
| | United States | 10 | 2024 | 15078 | 0.110 |
Why?
| | Eosinophils | 3 | 2023 | 322 | 0.110 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 9 | 0.100 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2014 | 114 | 0.100 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2013 | 25 | 0.100 |
Why?
| | Computational Biology | 1 | 2018 | 650 | 0.100 |
Why?
| | Receptors, Purinergic P2X7 | 1 | 2012 | 12 | 0.100 |
Why?
| | Software | 1 | 2018 | 670 | 0.100 |
Why?
| | Islets of Langerhans | 1 | 2019 | 792 | 0.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2021 | 649 | 0.100 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 911 | 0.100 |
Why?
| | Exons | 1 | 2014 | 354 | 0.100 |
Why?
| | Extracellular Matrix | 1 | 2016 | 541 | 0.090 |
Why?
| | Cysts | 1 | 2013 | 114 | 0.090 |
Why?
| | Dinoprostone | 2 | 2023 | 192 | 0.090 |
Why?
| | RNA, Small Interfering | 3 | 2019 | 626 | 0.090 |
Why?
| | Anaphylaxis | 1 | 2013 | 107 | 0.090 |
Why?
| | Recombinant Proteins | 2 | 2019 | 1355 | 0.090 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 414 | 0.090 |
Why?
| | Lipids | 3 | 2023 | 675 | 0.090 |
Why?
| | Peanut Hypersensitivity | 1 | 2013 | 147 | 0.090 |
Why?
| | Chromosome Mapping | 3 | 2020 | 505 | 0.090 |
Why?
| | Phenotype | 3 | 2014 | 3145 | 0.090 |
Why?
| | Beclomethasone | 1 | 2010 | 9 | 0.090 |
Why?
| | Precision Medicine | 1 | 2015 | 423 | 0.080 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 2010 | 25 | 0.080 |
Why?
| | Genetic Linkage | 1 | 2011 | 289 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2019 | 1986 | 0.080 |
Why?
| | Intestines | 1 | 2013 | 356 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 276 | 0.080 |
Why?
| | Promoter Regions, Genetic | 2 | 2013 | 1235 | 0.080 |
Why?
| | Mast Cells | 2 | 2025 | 149 | 0.080 |
Why?
| | Antigens, Bacterial | 1 | 2010 | 125 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5805 | 0.080 |
Why?
| | Alleles | 3 | 2019 | 891 | 0.080 |
Why?
| | Disaccharides | 1 | 2009 | 19 | 0.080 |
Why?
| | Genetic Loci | 1 | 2011 | 281 | 0.080 |
Why?
| | Vital Capacity | 1 | 2010 | 312 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2021 | 3029 | 0.070 |
Why?
| | Insecta | 1 | 2009 | 70 | 0.070 |
Why?
| | Environmental Pollutants | 1 | 2011 | 160 | 0.070 |
Why?
| | Mexico | 1 | 2009 | 232 | 0.070 |
Why?
| | San Francisco | 1 | 2008 | 58 | 0.070 |
Why?
| | Biopsy | 2 | 2025 | 1072 | 0.070 |
Why?
| | RNA | 2 | 2013 | 925 | 0.070 |
Why?
| | Isoenzymes | 1 | 2009 | 304 | 0.070 |
Why?
| | Substrate Specificity | 1 | 2009 | 385 | 0.070 |
Why?
| | Catalysis | 1 | 2009 | 320 | 0.070 |
Why?
| | Disease Models, Animal | 4 | 2021 | 4319 | 0.070 |
Why?
| | Primary Cell Culture | 2 | 2019 | 171 | 0.070 |
Why?
| | Molecular Structure | 1 | 2009 | 502 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 557 | 0.070 |
Why?
| | Odds Ratio | 3 | 2016 | 1084 | 0.070 |
Why?
| | S100 Proteins | 2 | 2018 | 37 | 0.070 |
Why?
| | Immunoglobulin E | 2 | 2025 | 331 | 0.070 |
Why?
| | Sex Factors | 2 | 2015 | 2052 | 0.070 |
Why?
| | Antiviral Agents | 2 | 2023 | 736 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 862 | 0.060 |
Why?
| | Monocytes | 2 | 2021 | 573 | 0.060 |
Why?
| | Keratins | 2 | 2019 | 171 | 0.060 |
Why?
| | Mucins | 2 | 2018 | 73 | 0.060 |
Why?
| | Binding Sites | 1 | 2009 | 1317 | 0.060 |
Why?
| | Airway Resistance | 1 | 2025 | 41 | 0.060 |
Why?
| | Kinetics | 1 | 2009 | 1649 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 2995 | 0.060 |
Why?
| | Administration, Intranasal | 1 | 2025 | 91 | 0.060 |
Why?
| | Demography | 2 | 2020 | 298 | 0.060 |
Why?
| | Virus Attachment | 1 | 2024 | 17 | 0.060 |
Why?
| | Phylogeny | 1 | 2009 | 1000 | 0.060 |
Why?
| | Infant | 4 | 2024 | 9586 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 25 | 0.050 |
Why?
| | ROC Curve | 1 | 2025 | 564 | 0.050 |
Why?
| | Homeostasis | 2 | 2020 | 614 | 0.050 |
Why?
| | Genetic Markers | 2 | 2018 | 344 | 0.050 |
Why?
| | Axonemal Dyneins | 1 | 2022 | 9 | 0.050 |
Why?
| | Socioeconomic Factors | 3 | 2016 | 1312 | 0.050 |
Why?
| | Th1 Cells | 1 | 2023 | 140 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 119 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2019 | 3705 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 226 | 0.050 |
Why?
| | Nippostrongylus | 1 | 2021 | 4 | 0.040 |
Why?
| | Alternaria | 1 | 2021 | 11 | 0.040 |
Why?
| | Afghanistan | 1 | 2021 | 79 | 0.040 |
Why?
| | Bronchoalveolar Lavage | 1 | 2021 | 92 | 0.040 |
Why?
| | Respiratory System | 1 | 2022 | 157 | 0.040 |
Why?
| | Esophageal Mucosa | 1 | 2020 | 22 | 0.040 |
Why?
| | Adoptive Transfer | 1 | 2021 | 222 | 0.040 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2020 | 21 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 136 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2024 | 260 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 539 | 0.040 |
Why?
| | Dominican Republic | 1 | 2019 | 24 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 3990 | 0.040 |
Why?
| | Interleukin-5 | 1 | 2020 | 42 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 761 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2020 | 163 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 334 | 0.040 |
Why?
| | Chemokine CCL26 | 1 | 2019 | 10 | 0.040 |
Why?
| | Water Loss, Insensible | 1 | 2019 | 4 | 0.040 |
Why?
| | Bleomycin | 1 | 2020 | 247 | 0.040 |
Why?
| | Arginase | 1 | 2019 | 28 | 0.040 |
Why?
| | Intermediate Filament Proteins | 1 | 2019 | 58 | 0.040 |
Why?
| | Eugenol | 1 | 2018 | 4 | 0.040 |
Why?
| | Acetophenones | 1 | 2018 | 14 | 0.040 |
Why?
| | Neutrophil Activation | 1 | 2019 | 85 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2021 | 1032 | 0.040 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 259 | 0.040 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2019 | 174 | 0.040 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2019 | 90 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2021 | 492 | 0.040 |
Why?
| | Metabolomics | 1 | 2024 | 689 | 0.040 |
Why?
| | Genes, T-Cell Receptor | 1 | 2018 | 9 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 320 | 0.040 |
Why?
| | Genes, Immunoglobulin | 1 | 2018 | 28 | 0.040 |
Why?
| | Immunomodulation | 1 | 2019 | 99 | 0.040 |
Why?
| | Research Design | 1 | 2024 | 1120 | 0.030 |
Why?
| | Smell | 1 | 2018 | 122 | 0.030 |
Why?
| | Receptors, Immunologic | 1 | 2019 | 213 | 0.030 |
Why?
| | Gene Ontology | 1 | 2017 | 53 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 68 | 0.030 |
Why?
| | Linear Models | 2 | 2010 | 855 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 593 | 0.030 |
Why?
| | Proteomics | 1 | 2024 | 1112 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1193 | 0.030 |
Why?
| | Chronic Disease | 1 | 2023 | 1804 | 0.030 |
Why?
| | Geography, Medical | 1 | 2016 | 11 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2019 | 501 | 0.030 |
Why?
| | Basophils | 1 | 2016 | 72 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2018 | 490 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2176 | 0.030 |
Why?
| | Public Health Surveillance | 1 | 2016 | 82 | 0.030 |
Why?
| | CD56 Antigen | 1 | 2015 | 34 | 0.030 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2015 | 57 | 0.030 |
Why?
| | Macrophages | 1 | 2023 | 1544 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3315 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2015 | 38 | 0.030 |
Why?
| | Morbidity | 1 | 2016 | 321 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2020 | 893 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2093 | 0.030 |
Why?
| | Organ Specificity | 1 | 2015 | 310 | 0.030 |
Why?
| | Exome | 1 | 2015 | 237 | 0.030 |
Why?
| | Integrin alpha6 | 1 | 2013 | 9 | 0.030 |
Why?
| | Tetraspanin 24 | 1 | 2013 | 7 | 0.030 |
Why?
| | Immunization | 1 | 2016 | 405 | 0.030 |
Why?
| | Thromboplastin | 1 | 2013 | 73 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 517 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2013 | 100 | 0.020 |
Why?
| | Pneumonia | 1 | 2019 | 644 | 0.020 |
Why?
| | Nuclear Pore | 1 | 2012 | 16 | 0.020 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2013 | 136 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2172 | 0.020 |
Why?
| | Gene Silencing | 1 | 2013 | 196 | 0.020 |
Why?
| | Age Factors | 1 | 2020 | 3276 | 0.020 |
Why?
| | Th17 Cells | 1 | 2013 | 108 | 0.020 |
Why?
| | Regeneration | 1 | 2013 | 198 | 0.020 |
Why?
| | Prednisone | 1 | 2012 | 226 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2013 | 819 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 468 | 0.020 |
Why?
| | Cell Lineage | 1 | 2013 | 350 | 0.020 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2011 | 19 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 2018 | 885 | 0.020 |
Why?
| | Bacteria | 1 | 2018 | 868 | 0.020 |
Why?
| | Microbiota | 1 | 2019 | 760 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3399 | 0.020 |
Why?
| | Risk | 1 | 2013 | 913 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1743 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1311 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2011 | 196 | 0.020 |
Why?
| | Receptors, Interleukin-6 | 1 | 2009 | 46 | 0.020 |
Why?
| | Suburban Population | 1 | 2008 | 18 | 0.020 |
Why?
| | Saliva | 1 | 2010 | 240 | 0.020 |
Why?
| | Reference Values | 1 | 2010 | 801 | 0.020 |
Why?
| | Michigan | 1 | 2008 | 129 | 0.020 |
Why?
| | Acculturation | 1 | 2007 | 54 | 0.020 |
Why?
| | Emigration and Immigration | 1 | 2007 | 50 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 3466 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5532 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2482 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2818 | 0.010 |
Why?
| | Environment | 1 | 2007 | 340 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2009 | 785 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 3999 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7686 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2008 | 6159 | 0.010 |
Why?
| | Pregnancy | 1 | 2008 | 6872 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2013 | 15919 | 0.010 |
Why?
|
|
Seibold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|